Received 24 March 2009; Accepted 11 November 2009; Published online 13 January 2010
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang1,10, Francisco J. Adrián2,10, Wolfgang Jahnke3, Sandra W. Cowan-Jacob3, Allen G. Li2, Roxana E. Iacob4, Taebo Sim1,5, John Powers6, Christine Dierks2, Fangxian Sun2, Gui-Rong Guo2, Qiang Ding2, Barun Okram7, Yongmun Choi1, Amy Wojciechowski1, Xianming Deng1, Guoxun Liu2, Gabriele Fendrich3, André Strauss3, Navratna Vajpai8, Stephan Grzesiek8, Tove Tuntland2, Yi Liu2, Badry Bursulaya2, Mohammad Azam6, Paul W. Manley3, John R. Engen4, George Q. Daley6, Markus Warmuth9 & Nathanael S. Gray
Код: Выделить всё
http://dx.doi.org/10.1038/nature08675